Percutaneous Coronary Intervention Market Research Report - Global Forecast till 2027

Global Percutaneous Coronary Intervention Market: Information by Product Type (Coronary Stents, PTCA Catheters, Coronary Guidewire and Accessories), by End User (Hospitals & Specialty Clinics, Ambulatory Surgical Centers, Research and Academic Institutes and others) and by Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2027

ID: MRFR/MED/2288-CR | July 2019 | Region: Global | 157 pages

Please note that the assessment period of report has been updated from 2018-2023 to 2020-2027. Cordially fill the sample form for updated data.

The Global Percutaneous Coronary Intervention Market is expected to register a CAGR of 7.1% to reach USD 15,205.4 Million till 2023. Percutaneous coronary intervention (PCI) is a procedure used to treat the narrowing of coronary arteries. In this procedure, a catheter is used to place a small structure, i.e., a stent to open blood vessels in the heart that have been narrowed owing to plaque build-up.


Factors such as the growing prevalence of cardiac diseases, the rising preference for minimally invasive procedures, and growing geriatric population that are more susceptible to these diseases are anticipated to propel the growth of the market over the forecast period. However, the stringent government regulations related to the procedure may hamper the growth of the market.


Market Dynamics


The increasing prevalence of heart disease has been considered to be one of the leading causes of death in men and women in recent years. Percutaneous coronary intervention (PCI) is used to treat acute heart attack, relieve angina (heart pain), prevent heart attack, and alleviate congestive heart failure, among others. PCI has been gaining significance in recent years owing to the growing prevalence of coronary heart diseases. According to the European Cardiovascular Disease Statistics 2017, each year, cardiovascular disease (CVD) causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union (EU). Additionally, cardiovascular disease accounts for about 45% of all the deaths in Europe and 37% of all deaths in the EU. Such a vast population suffering from kidney disease boosts market growth during the forecast period.


Global Percutaneous Coronary Intervention Market, by End User, 2017 & 2023 (USD Million)  Percutaneous coronary intervention Market


Source: MRFR Analysis


Segmentation


The global percutaneous coronary intervention market, by product type, has been segmented into coronary stents, PTCA catheters, coronary guidewire, and accessories. Based on end user, the percutaneous coronary intervention market has been classified as hospitals & specialty clinics, ambulatory surgical centers, research and academic institutes, and others.


Global Percutaneous coronary intervention Market Share, 2017 (%)  Percutaneous coronary intervention Market


Source: MRFR Analysis


Regional Analysis


The global percutaneous coronary intervention market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.


The Americas is expected to hold the largest share of the global percutaneous coronary intervention market. North America is expected to dominate the market, mainly due to the increasing awareness and the growing acceptability of percutaneous coronary intervention techniques.


Europe is expected to account for the second-largest market share during the forecast period. The factors responsible for market growth in this region are an increased number of hospitalizations for percutaneous coronary intervention techniques such as carotid artery angioplasty and cerebral angioplasty. According to a journal published by the Organization for Economic Co-operation and Development (OECD) in June 2015, there were 3.6 percutaneous coronary intervention (PCI) centers per million population in Poland. Europe holds a 31% market share in the global percutaneous coronary intervention market.


Asia-Pacific is estimated to be the fastest-growing region in the global market due to the increasing prevalence of cardiovascular diseases coupled with developing healthcare infrastructure and increasing disposable income.


The percutaneous coronary intervention market in the Middle East & Africa is expected to grow due to the high prevalence of the percutaneous coronary intervention in Saudi Arabia, Kuwait, and the UAE.  


Key Players


The prominent players in the global percutaneous coronary intervention market are Abbott (US), ASAHI INTECC Company Limited (Japan), B. Braun Melsungen AG (UK), Biosensors International Group, Ltd (Singapore), BIOTRONIK (US), Boston Scientific Corporation (US), C. R. Bard, Inc. (US), Comed BV (Netherlands), Cook (US), Cordis (US), Medtronic PLC (US), Meril Lifesciences Pvt. Ltd (India), Merit Medical System ( Utah), and Terumo Corporation ( Japan).


Some of the key strategies followed by players operating in the global percutaneous coronary intervention market were innovation, product development, and acquisition & mergers.



  • In January 2017, Abbott announced that it had completed the acquisition of St. Jude Medical, Inc., establishing the company as a leader in the medical device arena.



  • In June 2016, ASAHI INTECC Company Limited launched ASAHI Caravel microcatheter in the US. This launch gave Caravel the lowest crossing profile of any of the purely braided microcatheters in the US.



  • In April 2017, B. Braun Medical and Christie Medical Holdings, Inc. announced the collaboration aimed at improving Peripheral IV access.


Market Segmentation


Global Percutaneous Coronary Intervention Market, by Product Type



  • Coronary Stents

  • PTCA Catheters

  • Coronary Guidewire

  • Accessories                


Global Percutaneous Coronary Intervention Market, by End User



  • Hospitals & Specialty Clinics

  • Ambulatory Surgical Centers

  • Research and Academic Institutes

  • Others


Global Percutaneous Coronary Intervention Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • Latin America





  • Europe

    • Western Europe

      • Germany

      • UK

      • France

      • Italy

      • Spain

      • Rest of Western Europe



    • Eastern Europe





  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific





  • Middle East & Africa

    • Middle East

    • Africa




Available Additional Customizations



  • Company Profiles of Other Key Players

    • JOHNSON & JOHNSON

    • GETINGE AB

    • JUDE MEDICAL



  • Percutaneous Coronary Intervention Market, Industry Trends


Intended Audience



  • Pharmaceutical companies

  • Contract research manufacturing organizations

  • Research & development organizations

  • Academic institutes



Report Scope:
Report Attribute/Metric Details
  Market Size   USD 15,205.4 Million
  CAGR   7.1%
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product Type, End User and Region
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Abbott (US), ASAHI INTECC Company Limited (Japan), B. Braun Melsungen AG (UK), Biosensors International Group, Ltd (Singapore), BIOTRONIK (US), Boston Scientific Corporation (US), C. R. Bard, Inc. (US), Comed BV (Netherlands), Cook (US), Cordis (US), Medtronic PLC (US), Meril Lifesciences Pvt. Ltd (India), Merit Medical System ( Utah), and Terumo Corporation ( Japan)
  Key Market Opportunities   Favorable Reimbursement Scenario
  Key Market Drivers

  • Rising Prevalence Of Heart Diseases
  • Increasing Preference For Minimally Invasive Procedures
  • Increasing Geriatric Population


  • Frequently Asked Questions (FAQ) :


    Percutaneous coronary intervention market projected to grow at approximately 7.1% CAGR during the assessment period (2020-2027).

    The valuation of the global percutaneous coronary intervention market is estimated to increase to USD 15,205.4 MN by the end of 2023.

    In addition to the rising prevalence of chronic heart diseases, the increasing adoption of PCI procedures performed on patients with coronary artery disease and rising funding for R&D & clinical trials are major tailwinds pushing the growth of the global percutaneous coronary intervention market.

    North America holds the largest share in the global percutaneous coronary intervention market, followed by Europe and the Asia Pacific, respectively.

    Abbott (U.S.), Boston Scientific Corporation (U.S.), ASAHI INTECC Company Limited (Japan), Cordis (U.S.), Cook Medical (U.S.), Comed B.V. (The Netherlands), C. R. Bard, Inc. (U.S.), Biosensors International Group, Ltd. (Singapore), Meril Lifesciences Pvt Ltd. (India), Terumo Corporation (Japan), Medtronic Plc. (U.S.), B BIOTRONIK (U.S.), Braun Melsungen AG (Germany), and Merit Medical System (U.S.), are some of the top players operating in the global percutaneous coronary intervention market.

    Percutaneous Coronary Intervention Market - Summary


     Overview:
    Percutaneous coronary intervention (PCI) is a non-surgical procedure one of the two most common procedures performed on patients with coronary artery disease. It is used to treat narrowing arteries of the heart in coronary artery diseases including angina, acute myocardial infarction, and multivessel coronary artery disease (CAD), among others. 


    PCI procedures have increased steadily worldwide in recent years owing to the growing incidences of heart diseases.  Resultantly, the global percutaneous coronary intervention market is growing at a rapid pace.  Additionally, factors such as the increasing preference for minimally invasive procedures and increasing geriatric population drive the market growth.


    Furthermore, the increasing favorable reimbursement scenarios in certain developed countries are expected to contribute to the market growth in the future. For instance, in the US, Medicare provides reimbursement for PCI procedures in certain cases. In Germany, angioplasty with stenting using bare-metal stents is reimbursed solely via diagnosis-related group (DRG).


    In England, angioplasty with stenting using drug-eluting stents is reimbursed via a combination of diagnosis-related group (DRG). Conclusively, the presence of a favorable reimbursement scenario is expected to provide enormous opportunities for market growth over the assessment period (2018-2023).


    Whereas, the factors such as stringent government regulations for the approval of medical devices used in PCI procedures may hinder the market growth over the forecast period.


    Segmentation:
    Global Percutaneous Coronary Intervention Market has been segmented on the basis of product type, end-user, and regions.


    By product type, the market has been segmented into Coronary Stents, Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters, Coronary Guidewires, and Accessories among others.


    By end-user, the market has been segmented into Hospitals & Specialty Clinics, Ambulatory Surgical Centers, Research & Academic Institutes, and others.


    Regional Analysis:
    By Regions, the Global Percutaneous Coronary Intervention Market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa.


    The Americas region dominates the global percutaneous coronary intervention market mainly due to the higher health care expenditures and the increasing prevalence of coronary artery diseases among the growing population.


    Europe Percutaneous Coronary Intervention Market stands in the second position, globally mainly due to the rise in percutaneous coronary intervention centers in European countries.


    The Percutaneous Coronary Intervention Market in the Asia Pacific region is expected to emerge as a promising market, growing rapidly due to the increasing prevalence of cardiovascular diseases, rapidly developing healthcare infrastructure, and improving economic conditions in the region.


    Various factors influencing the investment opportunity in the market include the potential growth opportunities the market demonstrates, market competition, profitability, government regulation, demand for the products, innovation, research & development, strategic collaboration, joint venture, accusation, licensing, franchising, and cost of production.


    Key Players:
    Prominent players operating in the percutaneous coronary intervention market include Boston Scientific Corporation (U.S.), Abbott (U.S.), ASAHI INTECC Company Limited (Japan), C. R. Bard, Inc (U.S.), Comed B.V. (The Netherlands), Meril Lifesciences Pvt Ltd. (India), BIOTRONIK (U.S.), Medtronic Plc (U.S.), B. Braun Melsungen AG (Germany), Biosensors International Group, Ltd. (Singapore), Terumo Corporation (Japan), Cordis (U.S.), Cook Medical (U.S.), and Merit Medical System (U.S.).


    The Global Percutaneous Coronary Intervention Market witnesses a high degree of competition. The degree of product differentiation among existing players increases the intensity of competition in the market. To overcome the competition, the well-established players in this market are engaged in strategic collaborations and partnerships. The catheterization & stents manufacturing companies are trying to develop products with high quality, services, and enhanced safety to increase the demand for PCI devices in the developed as well as developing region.


    Additionally, the adoption of price control strategy provides a good opportunity for new entrants to introduce their PCI stents at low cost in the growing markets in APAC region to capture profitable share.


    There is a profitable investment opportunity for existing players and as well as new entrants, states the MRFR Experts.  Most of the market players are focusing on the development of bioresorbable stents considering the augmenting demand in the market which is expected to grow in the coming years.


    The existing players are also focusing on increasing their R&D and manufacturing activities and are acquiring promising companies engaged in manufacturing bioresorbable stents.


     

    1 Report Prologue

    2 Executive Summary

    3 Introduction

    3.1 Definition 20

    3.2 Scope Of The Study 20

    3.3 Assumptions & Limitations 21

    3.4 Market Structure 21

    4 Research Methodology

    4.1 Research Process 23

    4.2 Primary Research 24

    4.3 Secondary Research 25

    4.4 Market Size Estimation 25

    4.5 Forecast Model 26

    5 Market Dynamics

    5.1 Introduction 28

    5.2 Drivers 29

    5.2.1 Rising Prevalence Of Heart Diseases 29

    5.2.2 Increasing Preference For Minimally Invasive Procedures 29

    5.2.3 Increasing Geriatric Population 29

    5.3 Restraints 30

    5.3.1 Risk Of Infection 30

    5.3.2 Stringent Government Regulations 30

    5.4 Opportunities 30

    5.4.1 Favorable Reimbursement Scenario 30

    6 Market Factor Analysis

    6.1 Value Chain Analysis 32

    6.1.1 Research And Development 32

    6.1.2 Manufacturing 32

    6.1.3 Distribution & Sales 32

    6.1.4 Post-Sales Monitoring 32

    6.2 Porter’s Five Forces Model 33

    6.2.1 Bargaining Power Of Suppliers 33

    6.2.2 Bargaining Power Of Buyers 34

    6.2.3 Threat Of New Entrants 34

    6.2.4 Threat Of Substitutes 34

    6.2.5 Intense Rivalry 34

    6.3 Investment Opportunity Analysis 34

    6.4 Pricing Analysis 35

    6.5 Market Volume By Product Type 35

    7 Global Percutaneous Coronary Intervention Market By Product Type

    7.1 Overview 37

    7.2 Coronary Stents 38

    7.3 PTCA Catheters 39

    7.4 Coronary Guidewire 40

    7.5 Accessories 40

    8 Global Percutaneous Coronary Intervention Market By End-User

    8.1 Overview 43

    8.2 Hospitals & Specialty Clinics 44

    8.3 Ambulatory Surgical Centers 44

    8.4 Research And Academic Institutes 45

    8.5 Others 45

    9 Global Percutaneous Coronary Intervention Market By Region

    9.1 Overview 47

    9.2 Americas 49

    9.2.1 North America 52

    9.2.1.1 US 54

    9.2.1.2 Canada 56

    9.2.2 South America 57

    9.3 Europe 60

    9.3.1 Western Europe 63

    9.3.1.1 Germany 65

    9.3.1.2 France 67

    9.3.1.3 UK 68

    9.3.1.4 Italy 70

    9.3.1.5 Spain 72

    9.3.1.6 Rest Of Western Europe 73

    9.3.2 Eastern Europe 75

    9.4 Asia-Pacific 77

    9.4.1 Japan 79

    9.4.2 China 81

    9.4.3 India 83

    9.4.4 South Korea 84

    9.4.5 Australia 86

    9.4.6 Rest Of Asia-Pacific 88

    9.5 Middle East & Africa 90

    9.5.1 Middle East 92

    9.5.2 Africa 94

    10 Competitive Landscape

    10.1 Introduction 97

    10.2 Company Market Share Analysis 97

    11 Company Profile

    11.1 Abbott 100

    11.1.1 Company Overview 100

    11.1.2 Financial Overview 100

    11.1.3 Products Offering 101

    11.1.4 SWOT Analysis 101

    11.1.5 Key Developments 101

    11.1.6 Key Strategy 101

    11.2 ASAHI INTECC Company Limited 102

    11.2.1 Company Overview 102

    11.2.2 Financial Overview 102

    11.2.3 Key Developments 103

    11.2.4 SWOT Analysis 104

    11.2.5 Key Strategy 104

    11.3 B. Braun Melsungen AG 105

    11.3.1 Company Overview 105

    11.3.2 Financial Overview 105

    11.3.3 Products Offering 106

    11.3.4 SWOT Analysis 107

    11.3.5 Key Developments 107

    11.3.6 Key Strategy 107

    11.4 Biosensors International Group, Ltd. 108

    11.4.1 Company Overview 108

    11.4.2 Financial Overview 108

    11.4.3 Products Offering 108

    11.4.4 SWOT Analysis 108

    11.4.5 Key Developments 108

    11.4.6 Key Strategy 108

    11.5 BIOTRONIK 109

    11.5.1 Company Overview 109

    11.5.2 Products Offering 109

    11.5.3 SWOT Analysis 109

    11.5.4 Key Developments 110

    11.5.5 Key Strategy 110

    11.6 Boston Scientific Corporation 111

    11.6.1 Company Overview 111

    11.6.2 Financial Overview 111

    11.6.3 Products Offering 112

    11.6.4 Key Developments 112

    11.6.5 SWOT Analysis 113

    11.6.6 Key Strategy 113

    11.7 C. R. Bard, Inc. 114

    11.7.1 Company Overview 114

    11.7.2 Financial Overview 114

    11.7.3 Products Offering 115

    11.7.4 Key Developments 115

    11.7.5 SWOT Analysis 115

    11.7.6 Key Strategy 116

    11.8 Comed BV. 117

    11.8.1 Company Overview 117

    11.8.2 Financial Overview 117

    11.8.3 Products Offering 117

    11.8.4 SWOT Analysis 118

    11.8.5 Key Developments 118

    11.8.6 Key Strategy 118

    11.9 Cook 119

    11.9.1 Company Overview 119

    11.9.2 Financial Overview 119

    11.9.3 Products Offering 119

    11.9.4 SWOT Analysis 119

    11.9.5 Key Developments 120

    11.9.6 Key Strategy 120

    11.10 Cordis 121

    11.10.1 Company Overview 121

    11.10.2 Financial Overview 121

    11.10.3 Products Offering 122

    11.10.4 SWOT Analysis 122

    11.10.5 Key Development 122

    11.10.6 Key Strategy 122

    11.11 Medtronic PLC 123

    11.11.1 Company Overview 123

    11.11.2 Financial Overview 123

    11.11.3 Products Offering 124

    11.11.4 Key Developments 124

    11.11.5 SWOT Analysis 124

    11.11.6 Key Strategy 125

    11.12 Meril Lifesciences Pvt. Ltd 126

    11.12.1 Company Overview 126

    11.12.2 Financial Overview 126

    11.12.4 Key Developments 126

    11.12.5 SWOT Analysis 127

    11.12.6 Key Strategy 127

    11.13 Merit Medical System 128

    11.13.1 Company Overview 128

    11.13.2 Financial Overview 128

    11.13.3 Products Offering 129

    11.13.4 Key Developments 129

    11.13.5 SWOT Analysis 130

    11.13.6 Key Strategy 130

    11.14 Terumo Corporation 131

    11.14.1 Company Overview 131

    11.14.2 Financial Overview 131

    11.14.3 Products Offering 132

    11.14.4 Key Developments 132

    11.14.5 SWOT Analysis 133

    11.14.6 Key Strategy 133

    12 Appendix

    12.1 Discussion Blue Print 135

    13 List Of Tables

    TABLE 1 MARKET SYNOPSIS 18

    TABLE 2 LIST OF ASSUMPTIONS 21

    TABLE 3 PRIMARY INTERVIEWS 23

    TABLE 4 PORTER’S FIVE FORCES ANALYSIS: GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET 33

    TABLE 5 GLOBAL PCI MARKET VOLUME BY PRODUCT TYPE, 2020 (UNIT) 35

    TABLE 6 GLOBAL PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 37

    TABLE 7 GLOBAL PCI MARKET FOR CORONARY STENTS BY REGION, 2020 TO 2027 (USD MILLION) 38

    TABLE 8 GLOBAL PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 38

    TABLE 9 GLOBAL PCI MARKET FOR PTCA CATHETERS BY REGION, 2020 TO 2027 (USD MILLION) 39

    TABLE 10 GLOBAL PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 39

    TABLE 11 GLOBAL PCI MARKET FOR CORONARY GUIDEWIRE BY REGION, 2020 TO 2027 (USD MILLION) 40

    TABLE 12 GLOBAL PCI MARKET FOR ACCESSORIES BY REGION, 2020 TO 2027 (USD MILLION) 40

    TABLE 13 GLOBAL PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 41

    TABLE 14 GLOBAL PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 43

    TABLE 15 GLOBAL PCI MARKET FOR HOSPITALS & SPECIALTY CLINICS BY REGION, 2020 TO 2027 (USD MILLION) 44

    TABLE 16 GLOBAL PCI MARKET FOR AMBULATORY SURGICAL CENTERS BY REGION, 2020 TO 2027 (USD MILLION) 44

    TABLE 17 GLOBAL PCI MARKET FOR RESEARCH AND ACADEMIC INSTITUTES BY REGION, 2020 TO 2027 (USD MILLION) 45

    TABLE 18 GLOBAL PCI MARKET BY REGION, 2020 TO 2027 (USD MILLION) 48

    TABLE 19 AMERICAS PCI MARKET BY REGION, 2020 & 2027 (USD MILLION) 49

    TABLE 20 AMERICAS PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 50

    TABLE 21 AMERICAS PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 50

    TABLE 22 AMERICAS PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 50

    TABLE 23 AMERICAS PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 51

    TABLE 24 AMERICAS PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 51

    TABLE 25 NORTH AMERICA PCI MARKET BY COUNTRY, 2020 & 2027 (USD MILLION) 52

    TABLE 26 NORTH AMERICA PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 52

    TABLE 27 NORTH AMERICA PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 53

    TABLE 28 NORTH AMERICA PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 53

    TABLE 29 NORTH AMERICA PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 53

    TABLE 30 NORTH AMERICA PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 54

    TABLE 31 US PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 54

    TABLE 32 US PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 54

    TABLE 33 US PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 55

    TABLE 34 US PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 55

    TABLE 35 US PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 55

    TABLE 36 CANADA PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 56

    TABLE 37 CANADA PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 56

    TABLE 38 CANADA PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 56

    TABLE 39 CANADA PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 57

    TABLE 40 CANADA PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 57

    TABLE 41 SOUTH AMERICA PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 57

    TABLE 42 SOUTH AMERICA PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 58

    TABLE 43 SOUTH AMERICA PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 58

    TABLE 44 SOUTH AMERICA PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 58

    TABLE 45 SOUTH AMERICA PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 59

    TABLE 46 EUROPE PCI MARKET BY REGION, 2020 & 2027 (USD MILLION) 60

    TABLE 47 EUROPE PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 61

    TABLE 48 EUROPE PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 61

    TABLE 49 EUROPE PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 61

    TABLE 50 EUROPE PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 62

    TABLE 51 EUROPE PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 62

    TABLE 52 WESTERN EUROPE PCI MARKET BY COUNTRY, 2020 & 2027 (USD MILLION) 63

    TABLE 53 WESTERN EUROPE PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 63

    TABLE 54 WESTERN EUROPE PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 64

    TABLE 55 WESTERN EUROPE PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 64

    TABLE 56 WESTERN EUROPE PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 64

    TABLE 57 WESTERN EUROPE PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 65

    TABLE 58 GERMANY PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 65

    TABLE 59 GERMANY PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 65

    TABLE 60 GERMANY PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 66

    TABLE 61 GERMANY PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 66

    TABLE 62 GERMANY PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 66

    TABLE 63 FRANCE PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 67

    TABLE 64 FRANCE PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 67

    TABLE 65 FRANCE PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 67

    TABLE 66 FRANCE PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 68

    TABLE 67 FRANCE PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 68

    TABLE 68 UK PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 68

    TABLE 69 UK PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 69

    TABLE 70 UK PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 69

    TABLE 71 UK PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 69

    TABLE 72 UK PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 70

    TABLE 73 ITALY PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 70

    TABLE 74 ITALY PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 70

    TABLE 75 ITALY PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 71

    TABLE 76 ITALY PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 71

    TABLE 77 ITALY PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 71

    TABLE 78 SPAIN PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 72

    TABLE 79 SPAIN PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 72

    TABLE 80 SPAIN PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 72

    TABLE 81 SPAIN PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 73

    TABLE 82 SPAIN PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 73

    TABLE 83 REST OF WESTERN EUROPE PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 73

    TABLE 84 REST OF WESTERN EUROPE PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 74

    TABLE 85 REST OF WESTERN EUROPE PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 74

    TABLE 86 REST OF WESTERN EUROPE PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 74

    TABLE 87 REST OF WESTERN EUROPE PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 75

    TABLE 88 EASTERN EUROPE PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 75

    TABLE 89 EASTERN EUROPE PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 75

    TABLE 90 EASTERN EUROPE PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 76

    TABLE 91 EASTERN EUROPE PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 76

    TABLE 92 EASTERN EUROPE PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 76

    TABLE 93 ASIA-PACIFIC PCI MARKET BY COUNTRY, 2020 & 2027 (USD MILLION) 77

    TABLE 94 ASIA-PACIFIC PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 78

    TABLE 95 ASIA-PACIFIC PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 78

    TABLE 96 ASIA-PACIFIC PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 78

    TABLE 97 ASIA-PACIFIC PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 79

    TABLE 98 ASIA-PACIFIC PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 79

    TABLE 99 JAPAN PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 79

    TABLE 100 JAPAN PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 80

    TABLE 101 JAPAN PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 80

    TABLE 102 JAPAN PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 80

    TABLE 103 JAPAN PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 81

    TABLE 104 CHINA PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 81

    TABLE 105 CHINA PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 81

    TABLE 106 CHINA PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 82

    TABLE 107 CHINA PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 82

    TABLE 108 CHINA PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 82

    TABLE 109 INDIA PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 83

    TABLE 110 INDIA PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 83

    TABLE 111 INDIA PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 83

    TABLE 112 INDIA PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 84

    TABLE 113 INDIA PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 84

    TABLE 114 SOUTH KOREA PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 84

    TABLE 115 SOUTH KOREA PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 85

    TABLE 116 SOUTH KOREA PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 85

    TABLE 117 SOUTH KOREA PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 85

    TABLE 118 SOUTH KOREA PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 86

    TABLE 119 AUSTRALIA PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 86

    TABLE 120 AUSTRALIA PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 86

    TABLE 121 AUSTRALIA PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 87

    TABLE 122 AUSTRALIA PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 87

    TABLE 123 AUSTRALIA PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 87

    TABLE 124 REST OF ASIA-PACIFIC PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 88

    TABLE 125 REST OF ASIA-PACIFIC PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 88

    TABLE 126 REST OF ASIA-PACIFIC PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 88

    TABLE 127 REST OF ASIA-PACIFIC PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 89

    TABLE 128 REST OF ASIA-PACIFIC PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 89

    TABLE 129 MIDDLE EAST & AFRICA PCI MARKET BY REGION, 2020 & 2027 (USD MILLION) 90

    TABLE 130 MIDDLE EAST & AFRICA PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 91

    TABLE 131 MIDDLE EAST & AFRICA PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 91

    TABLE 132 MIDDLE EAST & AFRICA PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 91

    TABLE 133 MIDDLE EAST & AFRICA PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 92

    TABLE 134 MIDDLE EAST & AFRICA PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 92

    TABLE 135 MIDDLE EAST PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 92

    TABLE 136 MIDDLE EAST PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 93

    TABLE 137 MIDDLE EAST PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 93

    TABLE 138 MIDDLE EAST PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 93

    TABLE 139 MIDDLE EAST PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 94

    TABLE 140 AFRICA PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 94

    TABLE 141 AFRICA PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 94

    TABLE 142 AFRICA PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 95

    TABLE 143 AFRICA PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 95

    TABLE 144 AFRICA PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 95

    14 List Of Figures

    FIGURE 1 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET: MARKET STRUCTURE 21

    FIGURE 2 RESEARCH PROCESS 23

    FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH 26

    FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET 28

    FIGURE 5 SUPPLY CHAIN: GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET 32

    FIGURE 6 GLOBAL PCI MARKET BY PRODUCT TYPE, 2020 & 2027 (USD MILLION) 37

    FIGURE 7 GLOBAL PCI MARKET BY END-USER, 2020 & 2027 (USD MILLION) 43

    FIGURE 8 GLOBAL PCI MARKET BY REGION, 2020 (%) 47

    FIGURE 9 GLOBAL PCI MARKET BY REGION, 2020 & 2027 (USD MILLION) 47

    FIGURE 10 AMERICAS PCI MARKET BY REGION, 2020 (%) 49

    FIGURE 11 NORTH AMERICA PCI MARKET BY COUNTRY, 2020 (%) 52

    FIGURE 12 EUROPE PCI MARKET BY REGION, 2020 (%) 60

    FIGURE 13 WESTERN EUROPE PCI MARKET BY COUNTRY, 2020 (%) 63

    FIGURE 14 ASIA-PACIFIC PCI MARKET BY COUNTRY, 2020 (%) 77

    FIGURE 15 MIDDLE EAST & AFRICA PCI MARKET BY REGION, 2020 (%) 90

    FIGURE 16 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, MARKET SHARE ANALYSIS, 2020 (%) 97

    Global Percutaneous Coronary Intervention Market: Company Landscape


    The Global Percutaneous Coronary Intervention Market is dominated by several market players such as Abbott, B. Braun Melsungen AG, Boston Scientific Corporation, Cook Medical, Medtronic Plc, and others. Major players in the percutaneous coronary intervention market are opting for strategic collaborations and partnerships, and new product launches to brace their position in the market.


    Abbott accounted for the largest share in the global percutaneous coronary intervention market in the year 2017. The company employs a strategy of focusing on severe diseases, maintaining the quality of products by maximum automation and rising investment in research and development which helps the company in maintaining its market position. Additionally, the company is engaged in new product launches and strategic partnerships. For instance, in October 2017, Abbott announced an updated version of everolimus-eluting, metallic stent Xience with a new stent design, a new delivery system, and unique sizes. Also, in January 2017, the company announced that it had completed the acquisition of St. Jude Medical, Inc., establishing the company as a leader in the medical device arena.



    1. Braun Melsungen AG held the second largest share in the global percutaneous coronary intervention market in the year 2017. The company operates in four major divisions, namely, hospital care, Aesculap, outpatient market, and B. Braun Avitum, and has a wide range of products with about 5,000 products, out of which 95% of the products are manufactured by the company. Furthermore, the company is engaged in strategic collaborations and mergers which facilitates it to strengthen its position and expand its market presence globally. For instance, in April 2017, B. Braun Medical and Christie Medical Holdings, Inc. announced a collaboration aimed at improving the access of peripheral intravenous catheters.


    Boston Scientific Corporation held a prominent share in the year 2017. The company works collaboratively to resolve the toughest problems of healthcare industries by developing solutions for patients suffering from life-threatening circumstances. The company focuses on developing high-quality products by using less invasive techniques. High customer satisfaction level, exceptional performance in new markets, and strong brand portfolio add to the company’s competitive advantage. In October 2015, the company received the Food and Drug Administration (FDA) approval for SYNERGY Bioabsorbable Polymer Drug-Eluting Stent System for the treatment of coronary artery disease. With this approval, the company gained the rights to market the product in the US.


    Medtronic is also a renowned player in the global percutaneous coronary intervention market. With the acquisition of Covidien, Medtronic has augmented its ability to create meaningful innovations for hospitals and healthcare providers so that it can deliver the best care possible to patients around the world. The company focuses on new product launches for the expansion of its product portfolio. For instance, in February 2018, Medtronic launched the first 2.0 mm Drug-Eluting stent Resolute Onyx in the US. The new product is intended to help interventional cardiologists treat patients with coronary artery disease (CAD) who have small vessels.


    Terumo Medical Corporation is one of the major companies in the market. The company has successfully integrated small companies through mergers and acquisitions to build a strong supply chain network. By doing this, the company aims at strengthening its position in the market. For instance, in July 2018, the company acquired China-based Essen Technology to enter the drug-eluting stent market in China.


    Cordis is one of the key companies having unmatched offerings in cardiology devices. The company was acquired by Cardinal Health in October 2015. The company focuses on strategic partnerships and new innovative product launches for its expansion in the market. For instance, in October 2016, the company announced several new strategic distribution agreements in the interventional vascular business for the expansion of its product portfolio in selected countries. Also, in November 2017, Cordis and Medinol announced the US Food and Drug Administration (FDA) approval of the EluNIR drug-eluting stent (DES) for the treatment of patients with narrowing or blockages to their coronary arteries.


    Other companies in the percutaneous coronary intervention market are Cook Medical, C. R. Bard, Inc., Comed B.V., and Meril Lifesciences Pvt. Ltd, among others.